Ashley Zehnder
Co-Founder and CEO,
Fauna Bio
United States
Ashley Zehnder is a co-founder and Chief Executive Officer of Fauna Bio. Ashley has been recognized for her work by the SF Business Times Women Who Lead in Life Sciences, an Emerging Woman Founder in Bio by the Wave Summit, as well as representing Fauna Bio for the Fortune AI Minute. She has spoken at numerous events promoting the use of AI and novel genomics in drug discovery and mentors early stage founders through her work with On Deck Longevity Biotech and Nucleate Bio. She is a boarded avian veterinarian and her prior research focused on translational science, earning a PhD in Cancer Biology from Stanford. Her research works span >20 peer-reviewed publications, including Cell, Nature and Nature Medicine.
Sessions
-
17-Jun-2025257ABBridging the Biodata Gap: Revolutionizing AI's Impact in Biopharma by Creating ”Digital Twins” of the Natural World
-
18-Jun-2025206ABWeight Loss for Longevity? How Metabolic Drugs are Disrupting Chronic Disease and Improving Healthspan
-
19-Jun-2025210BReplacing Guesswork with Data: How Preclinical Human Models Are Driving More Predictive Drug Discovery
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}